MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial ResultsGlobeNewsWire • 04/29/21
Will MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should KnowZacks Investment Research • 04/22/21
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference CallGlobeNewsWire • 04/19/21
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel ImmunotherapyPRNewsWire • 04/15/21
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/26/21
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference CallGlobeNewsWire • 02/18/21
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with IncyteGlobeNewsWire • 02/11/21
MacroGenics Announces Publication of SOPHIA Trial Results for MARGENZA™ in JAMA OncologyGlobeNewsWire • 01/25/21
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® MoleculeGlobeNewsWire • 12/18/20
MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast CancerGlobeNewsWire • 12/16/20
MacroGenics Presents Tebotelimab Data in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma at the 2020 ASH Annual MeetingGlobeNewsWire • 12/07/20
MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 2020 ASH Annual MeetingGlobeNewsWire • 12/06/20
MacroGenics and EVERSANA Announce Agreement to Support the Potential Launch and Commercialization of MargetuximabGlobeNewsWire • 11/30/20
MacroGenics Announces Achievement of $25 Million in Milestones Related to Retifanlimab Collaboration with IncyteGlobeNewsWire • 11/30/20
MacroGenics: Q4 PDUFA Target Action Date, 2021 Expected Revenue Growth Of 116%, And $281M In Cash Make It A BuySeeking Alpha • 11/27/20
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial ResultsGlobeNewsWire • 11/04/20